Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-15, Stock:JNJ, The news for the past five days is as follows:
2019-04-08: NEWS1: What's Been Going On With Emerald Bioscience?.NEWS2: Company News For Apr 8, 2019.NEWS3: Company News For Apr 8, 2019.NEWS4: J&J Stock on an Uptrend This Year So Far: More Room to Run?.NEWS5: J&J Stock on an Uptrend This Year So Far: More Room to Run?.NEWS6: Aeglea (AGLE) Reports New Positive Data for Pegzilarginase.NEWS7: Aeglea (AGLE) Reports New Positive Data for Pegzilarginase.NEWS8: Here's Why Axsome Therapeutics Rocketed 78.8% Higher in March.NEWS9: Here's Why Axsome Therapeutics Rocketed 78.8% Higher in March.NEWS10: Aeglea (AGLE) Reports New Positive Data for Pegzilarginase.NEWS11: J&J Stock on an Uptrend This Year So Far: More Room to Run?.NEWS12: Company News For Apr 8, 2019.NEWS13: Johnson & Johnson (NYSE:JNJ) Insiders Have Been Selling.NEWS14: Here&apos;s Why Axsome Therapeutics Rocketed 78.8% Higher in March.NEWS15: Better Buy: AbbVie vs. Johnson & Johnson.NEWS16: Better Buy: AbbVie vs. Johnson & Johnson.
2019-04-09: NEWS1: These 10 VC-backed companies scored the biggest Bay Area exits in Q1.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.47%: What You Should Know.NEWS3: Children's National taps Johnson & Johnson for incubator at Walter Reed.NEWS4: Geron's Blood Cancer Candidate Creates Buying Opportunity, Needham Says In Upgrade.NEWS5: 10 Dow Jones Stocks Holding the Blue Chip Index Back.NEWS6: Earnings Preview: Johnson & Johnson (JNJ) Q1 Earnings Expected to Decline.NEWS7: Earnings Preview: Johnson & Johnson (JNJ) Q1 Earnings Expected to Decline.NEWS8: Earnings Preview: Johnson & Johnson (JNJ) Q1 Earnings Expected to Decline.NEWS9: Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients.NEWS10: Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients.NEWS11: Health Care Sector Update for 04/09/2019: VXRT, ZGNX, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/09/2019: VXRT, ZGNX, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Special Report: As Baby Powder concerns mounted, J&J focused marketing on minority, overweight women.NEWS14: Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients.NEWS15: Alcon tops $28 bln market cap in decade's biggest Swiss stock deal.
2019-04-10: NEWS1: Here's what to expect from the stock market next month.NEWS2: 9 Best Dividend Stocks to Buy for Every Investor.NEWS3: 9 Best Dividend Stocks to Buy for Every Investor.NEWS4: Ra Pharmaceuticals Closes End-of-Phase 2 Interaction with FDA.NEWS5: Drug manufacturers divided over jury trial in Oklahoma case.NEWS6: 5 Dow Jones Stocks Threatening Dow 26,000.NEWS7: J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?.NEWS8: J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?.NEWS9: Akebia Expands Vadadustat Licensing Deal With Vifor Pharma.NEWS10: Insiders Bullish on Certain Holdings of DIA.NEWS11: Insiders Bullish on Certain Holdings of DIA.NEWS12: Alkermes Reports Positive Data From Schizophrenia Study.NEWS13: Akebia Expands Vadadustat Licensing Deal With Vifor Pharma.NEWS14: J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?.NEWS15: Health Care Sector Update for 04/10/2019: PTE, PHAS, GH, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 04/10/2019: PTE, PHAS, GH, JNJ, PFE, ABT, MRK, AMGN.NEWS17: 5 Stocks to Prepare for a Global Economic Slowdown.NEWS18: 5 Stocks to Prepare for a Global Economic Slowdown.NEWS19: 5 Stocks to Prepare for a Global Economic Slowdown.NEWS20: Further reading.NEWS21: Johnson & Johnson (JNJ) Stock Moves -0.47%: What You Should Know.NEWS22: Johnson & Johnson (JNJ) Stock Moves -0.47%: What You Should Know.
2019-04-11: NEWS1: Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon.NEWS2: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS3: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS4: Biofreeze Owner Mulls $1 Billion Sale of Pain Relief Gel.NEWS5: Health Care Sector Update for 04/11/2019: JNJ,ICPT,INNT,SGEN.NEWS6: Health Care Sector Update for 04/11/2019: JNJ,ICPT,INNT,SGEN.NEWS7: Biotechnology Market on a Tear: 5 ETFs in Spotlight.NEWS8: What's in Store for Dow ETF in Q1 Earnings?.NEWS9: What's in Store for Dow ETF in Q1 Earnings?.NEWS10: What's in Store for Dow ETF in Q1 Earnings?.NEWS11: Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2019.NEWS14: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2019.NEWS15: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 12, 2019.NEWS16: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 12, 2019.
2019-04-12: NEWS1: J&J wins U.S. FDA approval for bladder cancer drug.NEWS2: Cramer&apos;s Game Plan: Remember this market &apos;has no memory&apos; this earnings season.NEWS3: Cramer's Game Plan: Remember this market 'has no memory' this earnings season.NEWS4: Earnings Optimism Following Bank Results.NEWS5: Earnings Optimism Following Bank Results.NEWS6: Doing Business in Lake Nona: Here's what's ahead for the growing community.NEWS7: Earnings Optimism Following Bank Results.NEWS8: The shadowy system behind the high price of your drugs.NEWS9: Forward Guidance Will Make or Break JNJ Earnings.NEWS10: Forward Guidance Will Make or Break JNJ Earnings.NEWS11: U.S. FDA approves J&J's bladder cancer drug.NEWS12: 3 Earnings Reports to Watch Next Week.NEWS13: Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal.NEWS14: Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal.NEWS15: XLV, FLN: Big ETF Outflows.NEWS16: XLV, FLN: Big ETF Outflows.NEWS17: iShares Core S&P 500 ETF Experiences Big Inflow.NEWS18: iShares Core S&P 500 ETF Experiences Big Inflow.NEWS19: Looking for a Growth Stock? 3 Reasons Why Johnson & Johnson (JNJ) is a Solid Choice.NEWS20: Looking for a Growth Stock? 3 Reasons Why Johnson & Johnson (JNJ) is a Solid Choice.NEWS21: Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal.NEWS22: Health Care Sector Update for 04/12/2019: TCON, XFOR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS23: Health Care Sector Update for 04/12/2019: TCON, XFOR, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS24: Forward Guidance Will Make or Break JNJ Earnings.NEWS25: Looking for a Growth Stock? 3 Reasons Why Johnson & Johnson (JNJ) is a Solid Choice.NEWS26: Johnson & Johnson Is a Great Company Trading at a Fair Price.NEWS27: Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon.NEWS28: Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon.

Answer: Rise